NO20022109D0 - Anvendelse av treosulfan for behandling av pasienter för benmargs- eller blodstamcelletansplantasjon - Google Patents
Anvendelse av treosulfan for behandling av pasienter för benmargs- eller blodstamcelletansplantasjonInfo
- Publication number
- NO20022109D0 NO20022109D0 NO20022109A NO20022109A NO20022109D0 NO 20022109 D0 NO20022109 D0 NO 20022109D0 NO 20022109 A NO20022109 A NO 20022109A NO 20022109 A NO20022109 A NO 20022109A NO 20022109 D0 NO20022109 D0 NO 20022109D0
- Authority
- NO
- Norway
- Prior art keywords
- treosulfan
- bone marrow
- patients
- treatment
- stem cell
- Prior art date
Links
- YCPOZVAOBBQLRI-WDSKDSINSA-N Treosulfan Chemical compound CS(=O)(=O)OC[C@H](O)[C@@H](O)COS(C)(=O)=O YCPOZVAOBBQLRI-WDSKDSINSA-N 0.000 title abstract 3
- 229960003181 treosulfan Drugs 0.000 title abstract 3
- 210000001185 bone marrow Anatomy 0.000 title abstract 2
- 210000004369 blood Anatomy 0.000 title 1
- 239000008280 blood Substances 0.000 title 1
- 238000011476 stem cell transplantation Methods 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 230000003750 conditioning effect Effects 0.000 abstract 1
- 230000003394 haemopoietic effect Effects 0.000 abstract 1
- 229960003444 immunosuppressant agent Drugs 0.000 abstract 1
- 239000003018 immunosuppressive agent Substances 0.000 abstract 1
- 210000000130 stem cell Anatomy 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Transplantation (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Saccharide Compounds (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19953517A DE19953517C1 (de) | 1999-11-05 | 1999-11-05 | Verwendung von Treosulfan zur Konditionierung von Patienten vor Knochemarktransplantation oder Blutstammzelltransplantation |
| PCT/EP2000/010871 WO2001032154A2 (de) | 1999-11-05 | 2000-11-03 | Verwendung von treosulfan zur konditionierung von patienten vor knochenmarktransplantation oder blutstammzelltransplantation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20022109D0 true NO20022109D0 (no) | 2002-05-02 |
| NO20022109L NO20022109L (no) | 2002-07-01 |
| NO329616B1 NO329616B1 (no) | 2010-11-22 |
Family
ID=7928187
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20022109A NO329616B1 (no) | 1999-11-05 | 2002-05-02 | Anvendelse av treosulfan for fremstilling av et farmasøytisk preparat til bruk i forbindelse med allogen transplantasjon av benmarg eller hematopoetiske stamceller |
| NO2019032C NO2019032I1 (no) | 1999-11-05 | 2019-07-23 | Treosulfan |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO2019032C NO2019032I1 (no) | 1999-11-05 | 2019-07-23 | Treosulfan |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7199162B1 (no) |
| EP (1) | EP1227808B1 (no) |
| JP (1) | JP4846151B2 (no) |
| AT (1) | ATE251455T1 (no) |
| AU (1) | AU777527B2 (no) |
| BG (1) | BG65845B1 (no) |
| CA (1) | CA2389896C (no) |
| CZ (1) | CZ299701B6 (no) |
| DE (2) | DE19953517C1 (no) |
| EA (1) | EA004543B1 (no) |
| ES (1) | ES2208435T3 (no) |
| HU (2) | HU227332B1 (no) |
| NO (2) | NO329616B1 (no) |
| PL (1) | PL212132B1 (no) |
| UA (1) | UA73961C2 (no) |
| WO (1) | WO2001032154A2 (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10237146A1 (de) | 2002-08-13 | 2004-03-04 | Medac Gesellschaft für klinische Spezialpräparate mbH | Verwendung von Treosulfan und Derivaten davon zur Behandlung der Multiplen Sklerose |
| EP3856346A1 (en) | 2018-09-26 | 2021-08-04 | medac Gesellschaft für klinische Spezialpräparate mbH | Crystalline form of treosulfan |
| ES2964602T3 (es) | 2018-09-26 | 2024-04-08 | Medac Ges Fuer Klinische Spezialpraeparate Mbh | Liofilizado de treosulfano |
| WO2020064816A1 (en) | 2018-09-26 | 2020-04-02 | Medac Gesellschaft für klinische Spezialpräparate mbH | Solution comprising treosulfan |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5376546A (en) * | 1991-11-04 | 1994-12-27 | Xoma Corporation | Analogs of ribosome-inactivating proteins |
| DE4421391C1 (de) * | 1994-06-18 | 1995-11-30 | Gsf Forschungszentrum Umwelt | Verwendung von Antikörpern gegen T-Zellen zur verlängerten Immunsuppression |
| WO2000045842A2 (en) * | 1999-02-04 | 2000-08-10 | The General Hospital Corporation | Methods for human allografting |
-
1999
- 1999-11-05 DE DE19953517A patent/DE19953517C1/de not_active Expired - Lifetime
-
2000
- 2000-03-11 UA UA2002054343A patent/UA73961C2/uk unknown
- 2000-11-03 DE DE50004024T patent/DE50004024D1/de not_active Expired - Lifetime
- 2000-11-03 US US10/129,352 patent/US7199162B1/en not_active Expired - Lifetime
- 2000-11-03 CA CA002389896A patent/CA2389896C/en not_active Expired - Lifetime
- 2000-11-03 AT AT00975995T patent/ATE251455T1/de not_active IP Right Cessation
- 2000-11-03 EP EP00975995A patent/EP1227808B1/de not_active Expired - Lifetime
- 2000-11-03 WO PCT/EP2000/010871 patent/WO2001032154A2/de active IP Right Grant
- 2000-11-03 JP JP2001534359A patent/JP4846151B2/ja not_active Expired - Fee Related
- 2000-11-03 HU HU0203277A patent/HU227332B1/hu active Protection Beyond IP Right Term
- 2000-11-03 EA EA200200535A patent/EA004543B1/ru not_active IP Right Cessation
- 2000-11-03 AU AU13918/01A patent/AU777527B2/en not_active Expired
- 2000-11-03 ES ES00975995T patent/ES2208435T3/es not_active Expired - Lifetime
- 2000-11-03 PL PL356240A patent/PL212132B1/pl unknown
- 2000-11-03 CZ CZ20021562A patent/CZ299701B6/cs unknown
-
2002
- 2002-05-02 NO NO20022109A patent/NO329616B1/no not_active IP Right Cessation
- 2002-06-04 BG BG106772A patent/BG65845B1/bg unknown
-
2019
- 2019-07-23 NO NO2019032C patent/NO2019032I1/no unknown
- 2019-09-18 HU HUS1900041 patent/HUS1900041I1/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1227808A2 (de) | 2002-08-07 |
| CA2389896A1 (en) | 2001-05-10 |
| US7199162B1 (en) | 2007-04-03 |
| EA200200535A1 (ru) | 2002-10-31 |
| JP4846151B2 (ja) | 2011-12-28 |
| NO329616B1 (no) | 2010-11-22 |
| PL356240A1 (en) | 2004-06-28 |
| CZ20021562A3 (cs) | 2002-10-16 |
| ES2208435T3 (es) | 2004-06-16 |
| EP1227808B1 (de) | 2003-10-08 |
| CA2389896C (en) | 2007-04-10 |
| UA73961C2 (uk) | 2005-10-17 |
| HUP0203277A2 (en) | 2003-01-28 |
| BG65845B1 (bg) | 2010-03-31 |
| DE19953517C1 (de) | 2001-08-09 |
| AU1391801A (en) | 2001-05-14 |
| PL212132B1 (pl) | 2012-08-31 |
| HU227332B1 (en) | 2011-03-28 |
| WO2001032154A3 (de) | 2002-01-24 |
| AU777527B2 (en) | 2004-10-21 |
| WO2001032154A2 (de) | 2001-05-10 |
| EA004543B1 (ru) | 2004-06-24 |
| JP2003513034A (ja) | 2003-04-08 |
| NO2019032I1 (no) | 2019-07-23 |
| ATE251455T1 (de) | 2003-10-15 |
| DE50004024D1 (de) | 2003-11-13 |
| HUS1900041I1 (hu) | 2019-10-28 |
| CZ299701B6 (cs) | 2008-10-22 |
| NO20022109L (no) | 2002-07-01 |
| BG106772A (bg) | 2003-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS1900041I1 (hu) | Treoszulfán alkalmazása betegek csontvelõ- és vér õssejt-transzplantáció elõtti kondicionálására | |
| DK1131096T3 (da) | Anti-CD20-antistofbehandling af patienter, der modtager knoglemarvs- eller periferisk blodstamcelletransplantationer | |
| EA199901107A1 (ru) | Системы и устройства для лечения переломов костей или больных костей с помощью расширяемых тел (варианты), стерильный набор инструментов для введения в кость (варианты) | |
| EA200600076A1 (ru) | Композиции и способы увеличения активности теломеразы | |
| ATE288932T1 (de) | Neue biomaterialien | |
| IL197686A0 (en) | Pharmaceutical compositions containing alpha-4 integrin antagonists and uses thereof in the treatment of multiple myeloma and diseases associated therewith | |
| SE9702860D0 (sv) | New use | |
| WO2004104166A3 (en) | Administration of hyaluronic acid to enhance the function of transplanted stem cells | |
| DE69924715D1 (de) | Verwendung von angiotensin analogen zur herstellung eines arzneimittels zur steigerung des ueberlebens der weissen blutzellen und mobilisierung von haematopoietischen stammzellen nach einer chemotherapeutischen behandlung | |
| DE60106002D1 (de) | Behandlung von hematopoietischen zellen mit cxcr4 agonisten | |
| ATE300310T1 (de) | Verfahren zur steigerung von hematopoietischen zellen | |
| ATE426402T1 (de) | Medizinische zusammensetzungen enthaltend 2-amino-2-a2-(4-octylphenyl)ethylupropan-1,3-di l | |
| ATE368455T1 (de) | Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz | |
| ATE359798T1 (de) | Verwendungvon dextransulfat zur behandlung von ibmir | |
| WO2005017160A3 (en) | Mobilization of hematopoietic cells | |
| ATE297217T1 (de) | Zusammensetzung zur vorbeugung und behandlung von transplantatabstossung | |
| ES2154290T3 (es) | Estimulacion de la diferenciacion celular por sindecano. | |
| DE60042210D1 (de) | Verwendung von cytokinen, zellen und mitogene zur hemmung der graft-versus-host krankheit | |
| WO2003001877A3 (en) | Methods for the diagnosis and treatment of cardiac tissue rejection | |
| BR9913846A (pt) | Antagonista receptor de quemocina e ciclosporina em terapia combinada | |
| WO2003059375A1 (fr) | Therapie complexe pour la regeneration des tissus | |
| GB9710698D0 (en) | Composition | |
| DE69931148D1 (de) | Behandlung von hiv infektionen | |
| WO2000022097A3 (en) | Periferal blood mensenchymal precursor cells | |
| PL343848A1 (en) | Novel benzimidazoles and benzoxazoles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| SPCF | Filing of supplementary protection certificate |
Free format text: PRODUCT NAME: TREOSULFAN; REG. NO/DATE: EU/1/18/1351 20190620 Spc suppl protection certif: 2019032 Filing date: 20190723 |
|
| CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: MEDAC GESELLSCHAFT FUER KLINISCHE SPEZIALPRAEP, DE |
|
| MK1K | Patent expired |